Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Pravastatin is marketed in Australia as Cholstat, Lipostat and Pravachol, among others.
“APX-PRAVASTATIN produces its lipid-lowering effect in two ways. First, as a consequence of its reversible inhibition of HMG-CoA reductase activity, it affects modest reductions in intracellular pools of cholesterol.”
“The plasma elimination half-life (T1/2) of pravastatin (oral) is between 1.5 and 2 hours.”
“Unlike simvastatin and atorvastatin, pravastatin is not significantly metabolised in vivo by cytochrome P450 3A4.”
Pravastatin is marketed in Australia as Cholstat, Lipostat and Pravachol, among others.
9 brand names are recorded against this substance from the TGA eBS Product Information repository. The full list is in the Also known as card.
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.